AWM
IDXX icon

Angeles Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Angeles Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$777K Buy
1,383
+204
+17% +$131K 0.04% 168
2025
Q4 		$798K Sell
1,179
-13
-1% -$8.85K 0.04% 152
2025
Q3 		$762K Buy
1,192
+10
+0.8% +$6.07K 0.05% 146
2025
Q2 		$634K Buy
1,182
+1
+0.1% +$478 0.04% 153
2025
Q1 		$496K Buy
1,181
+1
+0.1% +$434 0.04% 141
2024
Q4 		$488K Buy
1,180
+102
+9% +$44.7K 0.04% 145
2024
Q3 		$545K Buy
1,078
+25
+2% +$12.1K 0.05% 130
2024
Q2 		$513K Buy
1,053
+41
+4% +$20.6K 0.05% 126
2024
Q1 		$546K Buy
1,012
+83
+9% +$45.4K 0.05% 113
2023
Q4 		$516K Sell
929
-71
-7% -$33.3K 0.06% 109
2023
Q3 		$437K Buy
1,000
+1
+0.1% +$499 0.06% 98
2023
Q2 		$502K Hold
999
– – 0.07% 109
2023
Q1 		$500K Sell
999
-7
-0.7% -$3.35K 0.07% 112
2022
Q4 		$410K Buy
1,006
+66
+7% +$25.6K 0.07% 109
2022
Q3 		$306K Sell
940
-14
-1% -$5.14K 0.06% 121
2022
Q2 		$335K Buy
954
+14
+1% +$5.71K 0.07% 123
2022
Q1 		$514K Buy
+940
New +$494K 0.1% 106

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Angeles Wealth Management's IDXX Position: Q1 2026 in Review

Angeles Wealth Management increased its Idexx Laboratories (IDXX) stake by 17% in Q1 2026, buying an estimated $131K and bringing the position to 1,383 shares worth $777K. The position accounts for 0.04% of the portfolio, ranked #168.

Angeles Wealth Management first reported a position in IDXX in Q1 2022 and has held it in 17 quarters since. The position peaked at $798K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Angeles Wealth Management held 1,383 shares of Idexx Laboratories worth $777K as of Q1 2026.
  • Angeles Wealth Management bought 204 Idexx Laboratories shares in Q1 2026, an estimated $131K.
  • Idexx Laboratories made up 0.04% of Angeles Wealth Management's portfolio in Q1 2026, its #168 holding.
  • Angeles Wealth Management first reported a position in Idexx Laboratories in Q1 2022 and has held it in 17 quarters since.
  • Angeles Wealth Management's Idexx Laboratories position peaked at $798K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.